Birth of a world leader in animal health
The French pharmaceutical company Sanofi-Aventis and the U.S. Merck in a statement announcing the creation of a joint venture in animal health. Owned equally between the two groups, it is destined to become the world's number one industry with a combined turnover of approximately $ 5.3 billion, or 29% of the market.
Since July 29, 2009 and redeemed for $ 4 billion of Merck's participation in their previous joint venture Merial, Sanofi-Aventis had an option to meet with Merial, Intervet Schering-Plow Animal Health Division in the born merger between Merck and Schering Plow.
The deal values Merial to 8 billion dollars and Intervet Schering-Plow 8.5 billion.It already cost at Sanofi-Aventis 250 million dollars to establish an equal joint venture with Merck, and 750 million under the agreement of July 2009 the statement said.
The formation of this joint venture is subject to completion of definitive agreements, review by competition authorities in the United States, Europe and other countries . The completion of the transaction is expected during the next 12 months. Pending completion of the transaction, Merial and Intervet Schering-Plow continue to work independently.
The market for animal health has reached 19 billion dollars in 2008. Products for pets represent 40% of the market and 60% for animal production.The growth of this market should be about 5% per year during the next 5 years, supported by a growing demand for animal protein, and by the substantial need for care for pets.
ALSO READ:
"Sanofi Aventis ready to make savings in 2010
"Warren Buffett increased its stake in Sanofi